This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Joseph Vallner: Innovator in Transdermal Drug Delivery
Introduction
Joseph Vallner is a notable inventor based in Mountainview, CA (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the area of transdermal drug delivery systems. His innovative approach has led to the development of a unique drug administration patch that enhances the effectiveness of medication delivery.
Latest Patents
Joseph Vallner holds a patent for a "Single layer transdermal drug administration system." This patch is designed for the transdermal delivery of pharmaceutical drugs. It features a single mass of elastomer in which the active drug and a percutaneous absorption enhancer are homogeneously dispersed throughout. This innovative patch is especially well suited for delivering the beta.sub.2 adrenergic agonist drug albuterol. Vallner's work in this area has the potential to improve patient compliance and therapeutic outcomes.
Career Highlights
Throughout his career, Joseph Vallner has been associated with G.D. Searle & Company, where he has contributed to various projects aimed at advancing drug delivery technologies. His expertise in the field has positioned him as a key figure in the development of effective pharmaceutical solutions.
Collaborations
Joseph Vallner has collaborated with several talented individuals in his field, including Rajeev D. Gokhale and Hana Berger. These collaborations have fostered innovation and have been instrumental in the advancement of their shared goals in pharmaceutical research.
Conclusion
Joseph Vallner's contributions to transdermal drug delivery systems exemplify the impact of innovative thinking in the pharmaceutical industry. His patent for a single-layer transdermal drug administration system highlights his commitment to improving healthcare solutions. Vallner's work continues to inspire advancements in drug delivery technologies.